Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARα

被引:23
作者
Ammazzalorso, Alessandra [1 ]
D'Angelo, Alessandra [1 ]
Giancristofaro, Antonella [1 ]
De Filippis, Barbara [1 ]
Di Matteo, Mauro [1 ]
Fantacuzzi, Marialuigia [1 ]
Giampietro, Letizia [1 ]
Linciano, Pasquale [1 ]
Maccallini, Cristina [1 ]
Amoroso, Rosa [1 ]
机构
[1] Univ G DAnnunzio, Dipartimento Farm, I-66100 Chieti, Italy
关键词
PPARs; PPAR antagonist; Transactivation assay; FRET; PROLIFERATOR-ACTIVATED-RECEPTORS; NUCLEAR RECEPTORS; ENERGY-TRANSFER; GAMMA; AGONISTS; FAMILY; LIGAND; FUTURE; CELLS; FAT;
D O I
10.1016/j.ejmech.2012.10.019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The identification of novel PPAR ligands represents an attractive research to fully understand the complex biological pathways regulated by these receptors. Selective PPAR modulators, inverse agonists and antagonists of three PPAR isoforms could help to clarify biological effects on lipid and glucose homeostasis. Here we describe the identification of a group of N-(methylsulfonyl)amides, derived from PPAR alpha agonist carboxylic acids. Transactivation and FRET assay confirmed an antagonist behaviour on PPAR alpha for some of these compounds, with submicromolar IC50. A preliminary analysis on selectivity alpha/gamma revealed different profiles of inhibition or activation. (C) 2012 Published by Elsevier Masson SAS.
引用
收藏
页码:317 / 322
页数:6
相关论文
共 35 条
[1]   Benzothiazole-based N-(phenylsulfonyl)amides as a novel family of PPARα antagonists [J].
Ammazzalorso, Alessandra ;
Giancristofaro, Antonella ;
D'Angelo, Alessandra ;
De Filippis, Barbara ;
Fantacuzzi, Marialuigia ;
Giampietro, Letizia ;
Maccallini, Cristina ;
Amoroso, Rosa .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (16) :4869-4872
[2]   Structural analysis of nuclear receptors: From isolated domains to integral proteins [J].
Brelivet, Yann ;
Rochel, Natacha ;
Moras, Dino .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 348 (02) :466-473
[3]   Evolution of peroxisome proliferator-activated receptor agonists [J].
Chang, Feng ;
Jaber, Linda A. ;
Berlie, Helen D. ;
O'Connell, Mary Beth .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (06) :973-983
[4]   Update on Cardiovascular Safety of PPARgamma Agonists and Relevance to Medicinal Chemistry and Clinical Pharmacology [J].
Ciudin, Andreea ;
Hernandez, Cristina ;
Simo, Rafael .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (06) :585-604
[5]   Structure of the PPARα and -γ ligand binding domain in complex with AZ 242;: Ligand selectivity and agonist activation in the PPAR family [J].
Cronet, P ;
Petersen, JFW ;
Folmer, R ;
Blomberg, N ;
Sjöblom, K ;
Karlsson, U ;
Lindstedt, EL ;
Bamberg, K .
STRUCTURE, 2001, 9 (08) :699-706
[6]   Tryptophan-containing dipeptide derivatives as potent PPARγ antagonists: Design, synthesis, biological evaluation, and molecular modeling [J].
Deng, Guanghui ;
Liu, Zhiguo ;
Ye, Fei ;
Luo, Xiaomin ;
Zhu, Weiliang ;
Shen, Xu ;
Liu, Hong ;
Jiang, Hualiang .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (12) :2699-2716
[7]   Peroxisome proliferator-activated receptor α is involved in cardiomyocyte differentiation of murine embryonic stem cells in vitro [J].
Ding, Ling ;
Liang, Xingguang ;
Zhu, Danyan ;
Lou, Yijia .
CELL BIOLOGY INTERNATIONAL, 2007, 31 (09) :1002-1009
[8]   PPAR ligands for metabolic disorders [J].
Etgen, GJ ;
Mantlo, N .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (14) :1649-1661
[9]   PPAR modulators and PPAR pan agonists for metabolic diseases: The next generation of drugs targeting Peroxisome Proliferator-Activated Receptors? [J].
Feldman, P. L. ;
Lambert, M. H. ;
Henke, B. R. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (09) :728-749
[10]   Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease [J].
Fruchart, Jean-Charles .
ATHEROSCLEROSIS, 2009, 205 (01) :1-8